The U.S. Food and Drug Administration (FDA) has warned that the antibiotic azithromycin (sold as Zithromax) can alter the electrical activity of the heart and could lead to a potentially deadly irregular heart rhythm in patients taking the drug.
In making its assessment, the agency pointed to a study published in the New England Journal of Medicine last year, which showed that patients who took Zithromax, as compared to other antibiotics, had a higher risk of developing a fatal heart rhythm condition, also known as QT prolongation.
The FDA urged caution when prescribing the drug, especially to at-risk patients who take drugs for abnormal heart rhythms; those who have low levels of magnesium or potassium in their systems; patients with slower-than-normal heart rates; or individuals who suffer from torsades de pointes – a rare condition that affects normal heart rhythms.
The FDA also stated that other antibiotics in the same class as Zithromax, called macrolides, also pose a similar risk for causing irregular heart rhythms. The agency stated it has updated Zithromax labels to apprise doctors and patients of the antibiotic’s heart risks.
Pfizer Inc., the drug giant that manufacturers Zithromax, said in an emailed statement to Reuters that the new warning will affect relatively few who take the drug. However, patients who are concerned about taking it should talk to their doctors. Sales of Zithromax exceeded $450 million in 2011.
If you believe you or a loved one has been injured due to the adverse side effects of a prescription drug, the Ocala pharmaceutical injury attorneys at Farah & Farah would like to talk to you. You may be entitled to compensation for hospitalization, medical bills, pain and suffering, and other damages. Call us at (800) 533-3555 or contact us online to discuss your case and your legal options. The review of your case is free, with no obligation on your part.